Physician profile
Robert L Tiso
NPI 1942295092
$5,441.10
in general payments reported to CMS, 2019-2025
23 companies · $630 in 2025
The $630 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,236 · 2020: $12.89 · 2021: $839 · 2022: $1,113 · 2023: $626 · 2024: $985 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,240.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,494.08 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Vertiflex, INC. | $836.86 | 2019 | |
| Relievant Medsystems, INC. | $513.68 | 2021-2023 | Intracept |
| Abbott Laboratories | $470.49 | 2019-2025 | Eterna, Proclaim |
| Vertos Medical, INC. | $437.53 | 2019-2023 | Mild Device Kit |
| Stryker Corporation | $368.36 | 2024-2025 | Mild Device Kit, Mako |
| Spr Therapeutics, INC | $324.49 | 2022-2024 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $142.76 | 2020-2025 | Xtampza, Belbuca |
| Painteq LLC | $135.40 | 2024 | Painteq |
| Medtronic, INC. | $131.64 | 2024-2025 | Inceptiv |
| Saluda Medical Americas, INC. | $122.33 | 2024-2025 | Evoke |
| Curonix LLC | $99.89 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $69.32 | 2023-2025 | Qulipta |
| Pfizer INC. | $55.34 | 2023-2024 | |
| Nalu Medical, INC. | $49.55 | 2024 | Nalu Neurostimulation System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $37.47 | 2022-2023 | Austedo Xr |
| Scilex Pharmaceuticals INC. | $33.74 | 2019 | |
| Avanos Medical | $30.42 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.22 | 2022 | |
| Nevro Corp. | $25.88 | 2019 | |
| Sentynl Therapeutics, INC. | $13.19 | 2019 | |
| Medtronic USA, INC. | $13.00 | 2019 | |
| Fidia Pharma USA INC. | $7.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tiso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.